Live Ventures, Inc. is a holding company, which engages in the acquisition of domestic middle-market companies. It operates through the following segments: Retail, Flooring Manufacturing, Steel Manufacturing, and Corporate and Other. The Retail segment consists of Vintage Stock and ApplianceSmart. The Floor Manufacturing Segment includes Marquis Industries, Inc. which produces carpets, rugs, and hard surfaces. The Steel Manufacturing Segment focuses on Precision Industries, Inc., which produces alloy plate, tool steel plate, and ground flat stock, and The Kinetic Co., Inc. The Corporate and Other segment includes corporate general and administrative costs Salomon Whitney LLC (SW Financial), a variable interest entity (VIE), and operations of certain legacy product and service offerings. The company was founded in 1968 and is headquartered in Las Vegas, NV.

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Lifezone Metals Ltd. engages in the battery metals supply chain from resource extraction to metals production and recycling. It operates through Metals Extraction and Refining Business and Intellectual Property Licensing Business segments. The Metals Extraction and Refining Business segment consists of Lifezone's interest in KNL, comprising the Kabanga Nickel Project in Tanzania. The Intellectual Property Licensing Business segment refers to patents residing with and managed by Lifezone's subsidiary Lifezone Limited, a team of trained engineers and scientists based in Lifezone's newly acquired Simulus hydromet laboratory based in Perth. The company was founded by Keith Stuart Liddell in 2008 and is headquartered in Ramsay, Isle of Man.

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.

NET Power, Inc. is a clean energy technology company developing its proprietary NET Power Cycle, which transforms natural gas into low-cost, clean and reliable power. The company was founded on January 8, 2010 and is headquartered in Durham, NC.

Olink Holding AB engages in the provision of accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. It operates through the following segments: Kit, Service, and All Other Segments. The company was founded on December 13, 2018, and is headquartered in Uppsala, Sweden.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. It is a targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company's quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.